Analyzers
These analyzers are used for disease testing for heart disease, cancer, diabetes, infectious diseases and hormonal disorders related to lifestyle.
Analyzers
These analyzers are used for disease testing for heart disease, cancer, diabetes, infectious diseases and hormonal disorders related to lifestyle.
IMMUNOSTICS
AFIAS COVID-19 Ab automated immunoassay in conjunction with AFIAS-1 analyzer
The AFIAS COVID-19 Ab (in conjunction with AFIAS-1 analyzer) is a fluorescence Immunoassay intended for the qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in serum, plasma, venous whole blood or fingerstick capillary whole blood samples from individuals with current or prior COVID-19 infection. The AFIAS COVID-19 Ab is intended for use as an aid in identifying patients with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
AFIAS-1 is an automated immunoassay analyzer that detect or measures the concentration of target analyte in a clinical sample loaded onto a self-contained test cartridge which is then inserted in the analyzer to automatically complete further steps to display the test result.
AFIAS-1 uses a single channel, it is optimized for small and mid-sized hospitals (or clinics) testing up to 10 samples per hour. For some tests, such as TSH, CRP, PCT, and HbA1c, a quantitative test can be performed using a small sample 30uL of whole blood from a finger or heel using an applicable C-tip (capillary tip).
For information to enhance your AFIAS-1 experience or if you'd like more information on our all in one cartridge release schedule contact us here.
The AFIAS-1 features
-
Fully Automatic
-
LIS Connectivity
-
1 Testing Channel
-
Capillary Blood, Serum or Plasma
-
5" LCD Touch Screen
-
Keyboard adaptable
Covid-19 Ab Test
Ready
AFIAS COVID-19 Ab Test Cartridge
AFIAS COVID-19 Ab test cartridge is an unitized, self-contained, ready-to-use test device to be used in conjunction with AFIAS-1 or AFIAS-6 analyzer by simply loading the clinical sample onto the test cartridge thereby offering great convenience to the user. AFIAS-1 and AFIAS-6 analyzers qualitatively detects IgG/IgM antibodies to SARS-CoV-2 in serum, plasma, venous whole blood or fingerstick capillary whole blood samples to automatically display the result after 10 minutes. The AFIAS COVID-19 Ab test cartridge is marked with a barcode, which signifies the identity of the test cartridge after sample-loaded test cartridge is inserted in and scanned by the analyzer
Detection Buffer Well
Sample Well
Detection Zone
Loading Well
AFIAS-1 Technical Specifications for AFIAS COVID-19 Ab test
Throughput
Number of channels
Sample
Cartridge
Measuring principle
Monitor/Keyboard
Calibration
Connectivity
Power Input
Dimension / Weight
Instrument type
Temp. Range
10 min per test
Single Channel
Serum/plasma/venous whole blood (150µL to be added in the sample well of the test cartridge) Fingerstick capillary whole blood to be collected into the AFIAS C-tip (30 µL) directly from the patient
Ready to use “all in one cartridge”
Lateral flow sandwich detection immunofluorescence assay
5” LCD touch screen, built-in thermal printer, bluetooth keyboard (optional)
Master calibration formula provided through lot-specific test ID Chip.
User-level calibration not required for AFIAS COVID-19 Ab test
Factory calibration, 2-point calibration / ID Chip (Master Calibration Curve)
LIS/HIS compatible, RS 232, USB port
100 ~ 240 V AC (50/60 Hz) / 1.5 A
320 mm (L) x 204 mm (W) x 180 mm (H) / 3.9kg
Compact Automatic Immunoassay Analyzer
15 ~ 35 °C
AFIAS-1 Resources
AFIAS-1 - Video Introduction
AFIAS-1 Test Introduction